Are there patient populations in whom you would consider using both induction chemotherapy and maintenance pembrolizumab for a patient with locally advanced cervical cancer?  

This has been discussed but there is no current data on the combination of INTERLACE followed by A18. There are certain clinical situations (large tumor, node-positive) that I may consider it. But this would be on a case-to-case basis.